[Analysis of the efficiency of Gerigoa-depot in a double-blind study].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to W Jansen.
Explore the source record for details and available documents.
A new galenical formulation of the broad spectrum bactericidal agent, Eusaprim Suspension for Adults, has been tried in 121 geriatric patients presenting various infections, particularly of the urogenital tract, respiratory passages, gastrointestinal tract, as well as superinfections in decubitus, varicose ulcer and gangrene. No differences could be established compared to the tablet form. No side effects were observed and transient symptoms of intolerance were noted in only 4 cases. The suspension should be given preference in patients presenting difficulty in swallowing.
Largely confirmed Caird's figures. Using Schellong's test we recorded systolic pressure falls of 20 mm Hg and more in 25% of 160 residents in an old people's home in the age range 59-88 years. These cases of circulatory dysregulation were all manifestations of the hypodynamic form of the orthostatic syndrome. This means that only systolic blood pressure fell, diastolic pressure as well as heart rate being largely unaffected. The phenomenon appears to be due to age-related deterioration in circulatory regulation; at least no evidence has been found to suggest that it has a specific aetiology. In a double-blind cross-over study the effect of dihydroergotamine (DHE) was compared to placebo in 40 patients. Half the patients were given 2 mg DHE three times daily for 14 days and the other half placebo tablets; following one week's wash-out, the treatments were then reversed for a further 2-week period. Schellong's test (measurement of blood pressure and pulse after 10 minutes in the supine position and then after 1, 2, 5 and 10 minutes standing) was performed at the beginning and end of each treatment period. The average falls in upright systolic pressure for all 40 patients were as follows: before treatment 20 mm Hg, end of placebo periods 19 mm Hg, end of DHE periods 7 mm Hg. The differences between the values recorded after treatment with DHE and the other 2 values are statistically significant.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.